Abstract

BackgroundRepetitive transcranial magnetic stimulation (rTMS) is a noninvasive form of brain stimulation. It has been used in many mental health institutions to treat mental disorders worldwide. However, comprehensive knowledge about rTMS is not yet widespread among psychiatrists. The present study assessed psychiatrists’ knowledge and attitudes about rTMS in China and investigated related factors.MethodsA quantitative observational cross-sectional study was conducted using an online survey. The sample consisted of 522 psychiatrists. Multinomial logistic regression and multiple linear regression analyses were used to explore factors that contributed to psychiatrists’ knowledge about rTMS. We also ascertained psychiatrists’ attitudes about rTMS and provide recommendations for the more widespread use of rTMS.ResultsThe majority of respondents (86.4%) reported having access to rTMS at their institution. A total of 379 psychiatrists (72.6%) knew that rTMS was approved by the United States Food and Drug Administration for treatment-resistant depression. Univariate logistic regression indicated that psychiatrists who were older, had a senior professional title, worked more years, had an onsite clinical rTMS program in their hospital, and received formal training in theory and application (all p < 0.05) were more likely to know that rTMS was approved by the Food and Drug Administration for the treatment of depression. The percentages of respondents who knew most or all indications, the mechanism of action, parameter settings, adverse reactions were 51.9, 40.2, 27.4, and 41.4%. Linear regression showed that formal training in rTMS theory and practice were associated with higher knowledge scores (all p < 0.05). Most of the subjects had negative attitudes about using rTMS to treat mental disorders. When asked about their attitudes about continuing rTMS education, nearly all of the respondents indicated that they were willing to pursue continuing training in rTMS in the future.ConclusionsMany psychiatrists had an insufficient level of knowledge about rTMS and negative attitudes about rTMS. Psychiatrists who had formal rTMS training experience had higher levels of rTMS knowledge. rTMS training and relevant policy making should be strengthened.

Highlights

  • Repetitive transcranial magnetic stimulation is a noninvasive form of brain stimulation

  • We directed questionnaires to psychiatrists who worked in specialized psychiatric hospitals or in psychiatry departments of general hospitals and included all psychiatrists who agreed to participate in the selfadministered online survey

  • Questionnaire A self-designed questionnaire that investigated knowledge and attitudes about Repetitive transcranial magnetic stimulation (rTMS) among psychiatrists was used in the present study because we are unaware of such a questionnaire that has been previously validated (Table S1)

Read more

Summary

Introduction

Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive form of brain stimulation It has been used in many mental health institutions to treat mental disorders worldwide. RTMS is an approved noninvasive neuromodulation technique that activates or inhibits cortical activity [1]. Numerous clinical trials have confirmed that rTMS effectively treats mental disorders, such as depression, obsessivecompulsive disorder, auditory hallucinations, and negative symptoms of schizophrenia [2,3,4]. Health authorities in many countries (e.g., United States, Canada, Australia, and Germany) have approved rTMS as a treatment for depressive disorders. In China, rTMS has been used in hundreds of psychiatry departments to improve symptoms of mental disorders

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call